Observational studyHuman
Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects
Diabetes, 1995 Sep. Deacon CF, Nauck MA, Toft-Nielsen M and 3 others.
Study type
Observational study
Subjects
Human participants (PubMed MeSH: Humans)
Journal
Diabetes
Published
1995 Sep
PubMed
Indexed under
MeSH terms assigned by the National Library of Medicine.
AdultChromatography, High Pressure LiquidDiabetes Mellitus, Type 2Enzyme-Linked Immunosorbent AssayFemaleGlucagonGlucagon-Like Peptide 1Glucagon-Like PeptidesHumansInfusions, IntravenousInjections, SubcutaneousMale
PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.
Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page